Armune BioScience

Armune BioScience

Armune BioScience

Developed the technology APIFINY®—a prostate-cancer-specific non-PSA blood test that may improve decision making when selecting men for prostate biopsies.
Suggest edits
Founded
2005
Raised
$18.5M
Follow us
Companies in the same industry
Alexa global traffic share
Twitter followers
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 5

Add info
Add round
07 Sep 2016
$5,000,000
Venture capital (Series A)
Grand Angels Venture Fund II

Armune BioScience Closes $5M Series A Funding

FinSMEs
12 Jul 2016
$9,710,000
Venture capital (Series A)
Maverick Capital

Medical diagnostics startup secures $9M in funding

grbj
+2
20 Jan 2015
$3,537,583
Venture capital
22 Dec 2010
$250,000
Debt financing
25 Aug 2008
Venture capital